PROJECT V37.2 STATUS: 85% COMPLETE
PROVISIONAL PATENT 63/993,612 LOADING TIME...
Status Meter 85% of 100% Target
30%

0. Verification

Deterministic design audit completed. Zero-violation coordinates locked.

Completed
60%

1. Synthesis

Full chain elongation completed. Physical raw peptide cleaved and recovered.

Completed
90%

2. Purification

Transitioned to specialized heated preparative HPLC to polish the 4 mg physical sample.

Active
100%

3. Validation

CD shape test and SPR binding kinetics scheduled at Helix.

Pending
VERIFIED MASS SPEC: 1313.677 Da

CODE THE CURE.

The V37 Project Mission: take math, physics, and AI and write the code that can cure Cancer.

SECURED CANOPY: ROTATABLE WEBGL ENVIRONMENT

Interactive Target Action

Trigger the V37 therapeutic peptide to release the trapped p53 protein.

Simulation Telemetry

1. Sequestration
2. Alignment
3. Cleavage
4. Phase-Locked
Stability (G) -12.40 kcal/mol
Resonance Overlap (O) 0.0010
Verified Yield 4.0 mg
MDM2 Cancer Cleft (Target)
Native p53 (Natural Killer)
V37.2 Peptide (The Key)

THE KEY WE CODED

The Handcuffed Fighter

The human body already possesses a natural and highly effective tumor suppressor called the p53 protein. In half of all human cancers, the disease survives by overproducing an antagonist protein called MDM2, which physically binds to p53 and neutralizes it. This effectively holds the natural killer hostage, preventing the body from destroying the tumor. The body has its own cure, but cancer has it padlocked.

The Handcuffed Fighter

The Solution

Traditional drug discovery takes years and millions of dollars testing random chemicals, hoping one might be the key that fits the lock. We bypassed this slow, legacy model and used high-dimensional computational physics, math, and AI to design a custom molecular key called V37. In effect, we coded a key from scratch to target MDM2, pry it off p53, and reactivate the body's natural defense systems.

The Solution

Breaking the Lab

Because our molecular key is designed to bind to its target with extreme strength, it is highly dense and water-repelling. This caused the molecule to behave like an industrial adhesive inside standard automated manufacturing systems. It literally stuck to the inside of standard commercial purification machines. Standard automated factories simply could not process it.

Breaking the Lab

The Solution

We solved the physical bottleneck. We designed a custom purification protocol using high heat (60 degrees Celsius) and specialized Isopropanol solvent washes to pry the molecule out of the machines. Through these custom engineering interventions, we successfully recovered four milligrams of the physical molecule. High-resolution mass spectrometers analyzed the resulting sample and confirmed the exact molecular weight of our key down to the decimal point: 1313.677. The math is now tangible matter.

The Solution - Lab Success

Anatomical Anatomy

Crystallographic Blueprint

The V37 static ribbon demonstrates a strict 3.6 residues per turn periodicity. This geometry perfectly aligns what we call the 'Golden Triad' of hydrophobic residues (Phenylalanine, Tryptophan, and Leucine) onto a single binding face, ensuring high-affinity contact with the MDM2 cancer target.

Scientific Verifications

For clinical partners, investigators, and scientific supporters.

01 / wwPDB Sequence Alignment

To ensure we did not design a digital illusion, we processed our SC-V37.0 structural files through the official wwPDB validation server. The server validated 100 percent sequence-to-coordinate correspondence with zero geometric violations, certifying the output as a Valid mmCIF.

Entry ID

D_9100127558

Status

Valid mmCIF

02 / DiffDock Blind Docking Studies

DiffDock is an impartial molecular docking AI developed by MIT and NVIDIA. We conducted a strict blind test where the algorithm received zero hints about where the binding pocket was located. In 20 separate runs, the AI independently discovered the exact same solution: it located the specific hydrophobic cleft of MDM2 and anchored the V37 peptide into the correct functional pose 20 out of 20 times.

Convergence

20 / 20 (100%)

Calculated Stability

-50.79 kcal/mol

Resonance Overlap

0.4674 (O-Score)

03 / MolProbity Stereochemical Purity

Developed by Duke University, MolProbity acts as a stereochemical diagnostic. V37 achieved a MolProbity Score of 2.06, placing it in the 72nd percentile for structural quality. It demonstrated flawless backbone geometry with exactly zero bad bonds, zero bad angles, and zero atomic clashes.

Favored Ramachandran

100.0% (18/18)

Bad Bonds

0 / 119 (0.0%)

Bad Angles

0 / 157 (0.0%)

Clash Score

0.00 (Perfect)